Hyperprolactinemia

• FDA label_change · 2021-01-19
  FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

  The FDA approved a supplemental application for bromocriptine mesylate from Zydus Pharmaceuticals USA Inc., resulting in labeling changes fo…

• FDA label_change · 2013-06-12
  FDA Approved: CYCLOSET — Supplemental Application (Avvisto Therapeutics LLC)

  The FDA approved a supplemental application for CYCLOSET (bromocriptine mesylate) submitted by Avvisto Therapeutics LLC. The action involves…